Rbf Capital »

Adicet Bio Ord shares owned by Rbf Capital

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by Rbf Capital from 13F filings

Historical chart of Rbf Capital investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by Rbf Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by Rbf Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $325k 39k 8.42

More positions owned by Rbf Capital

Morgan Stanley Com New (MS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Applovin Corp Com Cl A (APP)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Bank of America Corporation (BAC)
Danaos Corporation SHS (DAC)
Alphabet Cap Stk Cl C (GOOG)
Mastercard Incorporated Cl A (MA)
Hca Holdings (HCA)
Fair Isaac Corporation (FICO)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Builders FirstSource (BLDR)

View all positions for Rbf Capital

Top funds holding Adicet Bio Ord

OrbiMed Advisors
RA Capital Management
Franklin Resources
Woodline Partners
Vanguard Group
Adage Capital Partners GP
Prosight Management
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
Two Sigma Investments
ADAR1 Capital Management

View all funds holding Adicet Bio Ord